Deerfield International Master Fund, L.P., 10% Owner at ANTARES PHARMA, INC. (ATRS), sold 231,793 shares at $2.12 ($503K) on 2015-07-20, disclosed to the SEC on 2015-07-21.
Open-market sale of $503k ATRS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.20 | 70,431 | $155K | 30.8% |
| 2 | $2.20 | 55,338 | $122K | 24.2% |
| 3 | $2.11 | 8,096 | $17K | 3.4% |
| 4 | $2.11 | 10,304 | $22K | 4.3% |
| 5 | $2.12 | 3,245 | $7K | 1.4% |
| 6 | $2.12 | 4,131 |
| $9K |
| 1.7% |
| 7 | $2.13 | 5,152 | $11K | 2.2% |
| 8 | $2.13 | 4,048 | $9K | 1.7% |
| 9 | $2.14 | 31,261 | $67K | 13.3% |
| 10 | $2.14 | 39,787 | $85K | 16.9% |
| Total | $2.17 avg | 231,793 | $503K | 100% |
| Filing → |
| VNDA | SELL | 2016-09-19 | $8.6M | — | Filing → |
| EHTH | SELL | 2016-06-08 | $488K | — | Filing → |
| ZFGN | BUY | 2016-02-17 | $177K | — | Filing → |